drugset / Trial / NCT03796507

Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation

NCT03796507

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the feasibility of a possible treatment regimen that could be used to delay tumor progression in patients with glioblastoma. The study is being conducted in patients who qualify for inpatient rehabilitation, as this population is particularly vulnerable to delays in initiation of chemoradiation and further tumor growth in the period between surgical resection and the start of treatment.

Timeline

Start
2021-09-01
Primary completion
2021-12-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule 75 mg/m2 Oral

Indications